These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20668898)

  • 1. Neuropsychological measures in clinical practice.
    Possa MF
    Neurol Sci; 2010 Nov; 31(Suppl 2):S219-22. PubMed ID: 20668898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuropsychological evaluation in multiple sclerosis].
    Arnett P; Forn C
    Rev Neurol; 2007 Feb 1-15; 44(3):166-72. PubMed ID: 17285522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in multiple sclerosis.
    Jongen PJ; Ter Horst AT; Brands AM
    Minerva Med; 2012 Apr; 103(2):73-96. PubMed ID: 22513513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological assessment: experimental and clinical research.
    Falautano M
    Neurol Sci; 2010 Nov; 31(Suppl 2):S223-6. PubMed ID: 20640469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive functioning in children and adolescents with multiple sclerosis.
    MacAllister WS; Belman AL; Milazzo M; Weisbrot DM; Christodoulou C; Scherl WF; Preston TE; Cianciulli C; Krupp LB
    Neurology; 2005 Apr; 64(8):1422-5. PubMed ID: 15851734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cognitive dysfunction in multiple sclerosis.
    Sartori E; Edan G
    J Neurol Sci; 2006 Jun; 245(1-2):169-75. PubMed ID: 16678209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.
    Benedict RH; Duquin JA; Jurgensen S; Rudick RA; Feitcher J; Munschauer FE; Panzara MA; Weinstock-Guttman B
    Mult Scler; 2008 Aug; 14(7):940-6. PubMed ID: 18573822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuropsychological profile of multiple sclerosis].
    Arango-Lasprilla JC; DeLuca J; Chiaravalloti N
    Psicothema; 2007 Feb; 19(1):1-6. PubMed ID: 17295976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.
    Morrow SA; O'Connor PW; Polman CH; Goodman AD; Kappos L; Lublin FD; Rudick RA; Jurgensen S; Paes D; Forrestal F; Benedict RH
    Mult Scler; 2010 Nov; 16(11):1385-92. PubMed ID: 20739335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropsychological evaluation and psychopathology of multiple sclerosis].
    Defer G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1128-34. PubMed ID: 11787345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM; Panegyres PK
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Audio Recorded Cognitive Screen (ARCS) in patients with multiple sclerosis: a practical tool for multiple sclerosis clinics.
    Lechner-Scott J; Kerr T; Spencer B; Agland S; Lydon A; Schofield PW
    Mult Scler; 2010 Sep; 16(9):1126-33. PubMed ID: 20621944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Faces Symbol Test, a newly developed screening instrument to assess cognitive decline related to multiple sclerosis: first results of the Berlin Multi-Centre FST Validation Study.
    Scherer P; Penner IK; Rohr A; Boldt H; Ringel I; Wilke-Burger H; Burger-Deinerth E; Isakowitsch K; Zimmermann M; Zahrnt S; Hauser R; Hilbert K; Tiel-Wilck K; Anvari K; Behringer A; Peglau I; Friedrich H; Plenio A; Benesch G; Ehret R; Nippert I; Finke G; Schulz I; Bergtholdt B; Breitkopf S; Kaskel P; Reischies F; Kugler J
    Mult Scler; 2007 Apr; 13(3):402-11. PubMed ID: 17439910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory decline evolves independently of disease activity in MS.
    Duque B; Sepulcre J; Bejarano B; Samaranch L; Pastor P; Villoslada P
    Mult Scler; 2008 Aug; 14(7):947-53. PubMed ID: 18573817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
    Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL
    J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid cognitive screening in multiple sclerosis accomplished by the Free Recall and Recognition Test.
    Claesson IM; Ytterberg C; Johansson S; Almkvist O; von Koch L
    Mult Scler; 2007 Mar; 13(2):272-4. PubMed ID: 17439898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuropsychological tests in multiple sclerosis].
    Takeda A
    Nihon Rinsho; 2014 Nov; 72(11):1989-94. PubMed ID: 25518382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropsychological evaluation in a case of multiple sclerosis].
    Sanz de la Torre JC; Pérez-Ríos M
    Rev Neurol; 2000 Jun 16-30; 30(12):1161-5. PubMed ID: 10935244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
    Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
    Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.